Skip to content

Oruka Therapeutics, Inc. ORKA Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent at other companies

Minerals Technologies logo
Minerals TechnologiesMTX
3.1%
NovaGold Resources logo
NovaGold ResourcesNG
0%0.0pp
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
0.7%+0.5pp
Trex Company logo
Trex CompanyTREX
0.3%-0.5pp
Cinemark Holdings logo
Cinemark HoldingsCNK
1.5%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-0.9%-1.8pp

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s effective income tax rate reconciliation other reconciling items percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s effective income tax rate reconciliation other reconciling items percent?
Oruka Therapeutics, Inc. (ORKA) reported effective income tax rate reconciliation other reconciling items percent of -0.9% in Q4 2025.
What does effective income tax rate reconciliation other reconciling items percent mean?
This represents the percentage impact of miscellaneous reconciling items on the effective tax rate relative to the statutory rate. It helps investors understand the magnitude of non-recurring or minor tax adjustments on the company's bottom line.